Sabrina Shearer, MD, FAAD
SESSIONS
F070 The Morbilliform Eruption: Differentiation and Treatment of Viral, Low-risk Drug, Severe Cutaneous Adverse Reactions, and GVHD
Mar 9, 2025
•
3:30 PM - 5:30 PM
•
W204C
DISCLOSURES
Bausch Health – Stockholder(Stock); IPG Photonics – Stockholder(Stock);